Crossmark

SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries

Published Online: 2020-01-24

Published Print: 2020-03

Authors

Janson, Christer

Menzies-Gow, Andrew

Nan, Cassandra

Nuevo, Javier

Papi, Alberto

Quint, Jennifer K.

Quirce, Santiago

Vogelmeier, Claus F.
Funding

Funding for this research was provided by:

AstraZeneca
License Information

Text and Data Mining valid from 2020-01-24

Version of Record valid from 2020-01-24
More Information

Article History

Received: 20 December 2019

First Online: 24 January 2020

Document is current